134 related articles for article (PubMed ID: 36164870)
1. [Ginkgo biloba Ketone Ester Tablets with different release rates prepared by fused deposition modeling 3D printing technology].
Li YY; Chen C; Wang HX; Xiang BB; Li Z
Zhongguo Zhong Yao Za Zhi; 2022 Sep; 47(17):4643-4649. PubMed ID: 36164870
[TBL] [Abstract][Full Text] [Related]
2. [Preparation and
Kaidierya A; Zhang RG; Qian HN; Zou ZY; Danniya Y; Fan TY
Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 54(6):1202-1207. PubMed ID: 36533356
[TBL] [Abstract][Full Text] [Related]
3. An Effective Technology for the Development of Immediate Release Solid Dosage Forms Containing Low-Dose Drug: Fused Deposition Modeling 3D Printing.
Gültekin HE; Tort S; Acartürk F
Pharm Res; 2019 Jun; 36(9):128. PubMed ID: 31250313
[TBL] [Abstract][Full Text] [Related]
4. Fabrication of timed-release indomethacin core-shell tablets for chronotherapeutic drug delivery using dual nozzle fused deposition modeling (FDM) 3D printing.
Chung S; Zhang P; Repka MA
Eur J Pharm Biopharm; 2023 Jul; 188():254-264. PubMed ID: 37201727
[TBL] [Abstract][Full Text] [Related]
5. Hydrophilic excipients in digital light processing (DLP) printing of sustained release tablets: Impact on internal structure and drug dissolution rate.
Krkobabić M; Medarević D; Cvijić S; Grujić B; Ibrić S
Int J Pharm; 2019 Dec; 572():118790. PubMed ID: 31678382
[TBL] [Abstract][Full Text] [Related]
6. Simplification of fused deposition modeling 3D-printing paradigm: Feasibility of 1-step direct powder printing for immediate release dosage form production.
Fanous M; Gold S; Muller S; Hirsch S; Ogorka J; Imanidis G
Int J Pharm; 2020 Mar; 578():119124. PubMed ID: 32035253
[TBL] [Abstract][Full Text] [Related]
7. Formulation of 3D Printed Tablet for Rapid Drug Release by Fused Deposition Modeling: Screening Polymers for Drug Release, Drug-Polymer Miscibility and Printability.
Solanki NG; Tahsin M; Shah AV; Serajuddin ATM
J Pharm Sci; 2018 Jan; 107(1):390-401. PubMed ID: 29066279
[TBL] [Abstract][Full Text] [Related]
8. Low temperature fused deposition modeling (FDM) 3D printing of thermolabile drugs.
Kollamaram G; Croker DM; Walker GM; Goyanes A; Basit AW; Gaisford S
Int J Pharm; 2018 Jul; 545(1-2):144-152. PubMed ID: 29705104
[TBL] [Abstract][Full Text] [Related]
9. [Preparation and
Chen D; Xu XY; Wang MR; Li R; Zang GA; Zhang Y; Qian HN; Yan GR; Fan TY
Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Mar; 53(2):348-354. PubMed ID: 33879910
[TBL] [Abstract][Full Text] [Related]
10. Development of immediate release 3D-printed dosage forms for a poorly water-soluble drug by fused deposition modeling: Study of morphology, solid state and dissolution.
Fanous M; Bitar M; Gold S; Sobczuk A; Hirsch S; Ogorka J; Imanidis G
Int J Pharm; 2021 Apr; 599():120417. PubMed ID: 33647418
[TBL] [Abstract][Full Text] [Related]
11. A Lower Temperature FDM 3D Printing for the Manufacture of Patient-Specific Immediate Release Tablets.
Okwuosa TC; Stefaniak D; Arafat B; Isreb A; Wan KW; Alhnan MA
Pharm Res; 2016 Nov; 33(11):2704-12. PubMed ID: 27506424
[TBL] [Abstract][Full Text] [Related]
12. Role of release modifiers to modulate drug release from fused deposition modelling (FDM) 3D printed tablets.
Shi K; Salvage JP; Maniruzzaman M; Nokhodchi A
Int J Pharm; 2021 Mar; 597():120315. PubMed ID: 33540000
[TBL] [Abstract][Full Text] [Related]
13. [Preparation and
Li ZS; Qian HN; Fan TY
Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Jun; 54(3):572-577. PubMed ID: 35701138
[TBL] [Abstract][Full Text] [Related]
14. 3D printing of modified-release aminosalicylate (4-ASA and 5-ASA) tablets.
Goyanes A; Buanz AB; Hatton GB; Gaisford S; Basit AW
Eur J Pharm Biopharm; 2015 Jan; 89():157-62. PubMed ID: 25497178
[TBL] [Abstract][Full Text] [Related]
15. Structure-Based Gastro-Retentive and Controlled-Release Drug Delivery with Novel 3D Printing.
Wen H; He B; Wang H; Chen F; Li P; Cui M; Li Q; Pan W; Yang X
AAPS PharmSciTech; 2019 Jan; 20(2):68. PubMed ID: 30627938
[TBL] [Abstract][Full Text] [Related]
16. Tailoring amlodipine release from 3D printed tablets: Influence of infill patterns and wall thickness.
Obeid S; Madžarević M; Ibrić S
Int J Pharm; 2021 Dec; 610():121261. PubMed ID: 34742830
[TBL] [Abstract][Full Text] [Related]
17. An investigation into the use of polymer blends to improve the printability of and regulate drug release from pharmaceutical solid dispersions prepared via fused deposition modeling (FDM) 3D printing.
Alhijjaj M; Belton P; Qi S
Eur J Pharm Biopharm; 2016 Nov; 108():111-125. PubMed ID: 27594210
[TBL] [Abstract][Full Text] [Related]
18. Adaptation of pharmaceutical excipients to FDM 3D printing for the fabrication of patient-tailored immediate release tablets.
Sadia M; Sośnicka A; Arafat B; Isreb A; Ahmed W; Kelarakis A; Alhnan MA
Int J Pharm; 2016 Nov; 513(1-2):659-668. PubMed ID: 27640246
[TBL] [Abstract][Full Text] [Related]
19. Fabrication of bilayer tablets using hot melt extrusion-based dual-nozzle fused deposition modeling 3D printing.
Zhang P; Xu P; Chung S; Bandari S; Repka MA
Int J Pharm; 2022 Aug; 624():121972. PubMed ID: 35787460
[TBL] [Abstract][Full Text] [Related]
20. 3D printed extended release tablets for once daily use: An in vitro and in vivo evaluation study for a personalized solid dosage form.
Gültekin HE; Tort S; Tuğcu-Demiröz F; Acartürk F
Int J Pharm; 2021 Mar; 596():120222. PubMed ID: 33484916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
